RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Michael Schmitt, Anita Schmitt, Markus Rojewski, +17

Blood

Mutated regions of nucleophosmin 1 elicit both CD4+ and CD8+ T-cell responses in patients with acute myeloid leukemia

Jochen Greiner, Yoko Ono, Susanne Hofmann, +8

Blood

Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens

Fei Fei, Yingzhe Yu, Anita Schmitt, +8

Experimental Hematology

Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyHematologyAutoimmunity +9

Dasatinib inhibits the proliferation and function of CD4⁺CD25⁺ regulatory T cells

Fei Fei, Yingzhe Yu, Anita Schmitt, +6

British Journal of Haematology

Donor Lymphocyte Infusion Induces Polyspecific CD8⁺ T-Cell Responses With Concurrent Molecular Remission in Acute Myeloid Leukemia With <i>NPM1</i> Mutation

Susanne Hofmann, Marlies Götz, Vanessa Schneider, +5

Journal of Clinical Oncology

Hematological MalignancyAcute Myeloid LeukemiaImmunologyTumor ImmunityHematology +7

Multimer Staining of Cytomegalovirus Phosphoprotein 65–Specific T Cells for Diagnosis and Therapeutic Purposes: A Comparative Study

Junxia Yao, Clemens Bechter, Markus Wiesneth, +12

Clinical Infectious Diseases

PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)

Lars Bullinger, Richard F. Schlenk, Marlies Götz, +10

Clinical Cancer Research

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy

Lisa K. Puntigam, S Jeske, Marlies Götz, +8

International Journal of Molecular Sciences

Effects of nilotinib on regulatory T cells: the dose matters

Fei Fei, Yingzhe Yu, Anita Schmitt, +6

Molecular Cancer

Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic <scp>T</scp> cells against immunogenic leukemia‐associated antigens

Vanessa Schneider, Lu Zhang, Markus Rojewski, +12

International Journal of Cancer